Search Results

UNC669 25mg  | 98.48%

APEXBIO TECHNOLOGY LLC

L3MBTL antagonist,potent and selective Chromatin/Epigenetics|Bromodomain

More Information Supplier Page

×

UNC669

PF-04880594 5mg  | 98%

APEXBIO TECHNOLOGY LLC

RAF inhibitor MAPK Signaling|Raf

More Information Supplier Page

×

PF-04880594

PF-04880594 25mg  | 98%

APEXBIO TECHNOLOGY LLC

RAF inhibitor MAPK Signaling|Raf

More Information Supplier Page

×

PF-04880594

PD173955 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

Dual Src/Abl kinase inhibitor, ATP-competitive, TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

PD173955

PD173955 Evaluation Sample  | 98%

APEXBIO TECHNOLOGY LLC

Dual Src/Abl kinase inhibitor, ATP-competitive, TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

PD173955

UNC669 10mg  | 98.48%

APEXBIO TECHNOLOGY LLC

L3MBTL antagonist,potent and selective Chromatin/Epigenetics|Bromodomain

More Information Supplier Page

×

UNC669

UNC669 10mM (in 1mL DMSO)  | 98.48%

APEXBIO TECHNOLOGY LLC

L3MBTL antagonist,potent and selective Chromatin/Epigenetics|Bromodomain

More Information Supplier Page

×

UNC669

Vorapaxar 50mg  | 98.58%

APEXBIO TECHNOLOGY LLC

PAR-1 antagonist,potent and orally active Others|Others

More Information Supplier Page

×

Vorapaxar

Vorapaxar 25mg  | 98.58%

APEXBIO TECHNOLOGY LLC

PAR-1 antagonist,potent and orally active Others|Others

More Information Supplier Page

×

Vorapaxar

Vorapaxar 10mg  | 98.58%

APEXBIO TECHNOLOGY LLC

PAR-1 antagonist,potent and orally active Others|Others

More Information Supplier Page

×

Vorapaxar